Incidence of Major Bleeding Complication of Warfarin Therapy in Japanese Patients With Atrial Fibrillation
Open Access
- 1 January 2007
- journal article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 71 (5), 761-765
- https://doi.org/10.1253/circj.71.761
Abstract
Background During anticoagulation for prevention of stroke in patients with non-valvular atrial fibrillation (NVAF), bleeding is the most serious complication. In Western countries, the incidences of major bleeding and intracranial hemorrhages with low-dose warfarin are known to occur at a rate of 0.4-1.3% and 0.2% per year, respectively. The purpose of this study was to investigate the incidence and risk factors for major bleeding related with warfarin therapy in Japanese patients with NVAF. Methods and Results From August 2004 to July 2005, 667 NVAF patients treated with warfarin for NVAF were followed-up. The target prothrombin time-international normalized ratio (PT-INR) value was set at 1.6-2.6 (low-dose warfarin). The exposure on warfarin was 503 patient-years (average PT-INR 2.00 ±0.40). During the follow-up period, 12 major bleeding complications occurred (2.38% per patient-year), which included 3 intracranial hemorrhages (0.60% per patient-year). Among the patients' characteristics, average PT-INR ≥2.27 during the study was identified as an independent risk factor for major bleeding. Conclusions The incidence of major bleeding and intracranial hemorrhages in Japanese NVAF patients with low-dose warfarin therapy was 2.38% and 0.60% per patient-year, respectively, which is higher than in Westerners. (Circ J 2007; 71: 761 - 765)Keywords
This publication has 21 references indexed in Scilit:
- Accumulation of Risk Factors Increases Risk of Thromboembolic Events in Patients With Nonvalvular Atrial FibrillationCirculation Journal, 2006
- Pharmacological Conversion of Persistent Atrial Fibrillation Into Sinus Rhythm With Oral PilsicainideCirculation Journal, 2006
- Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial FibrillationStroke, 2000
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996
- Contrast sonography for detection of vesicoureteral refluxThe Lancet, 1994
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJournal of the American College of Cardiology, 1991
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1990
- PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATIONThe Lancet, 1989